Prana Biotechnology (PRAN) Trading Down 5.3%

Share on StockTwits

Prana Biotechnology Limited (NASDAQ:PRAN) shares traded down 5.3% during mid-day trading on Tuesday . The company traded as low as $1.41 and last traded at $1.42. 560,972 shares were traded during trading, a decline of 13% from the average session volume of 644,214 shares. The stock had previously closed at $1.50.

Separately, ValuEngine downgraded Prana Biotechnology from a “buy” rating to a “hold” rating in a report on Wednesday, January 2nd.

The firm has a market cap of $12.64 million, a price-to-earnings ratio of -2.29 and a beta of 0.22.

ILLEGAL ACTIVITY NOTICE: This news story was posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this news story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be read at https://www.tickerreport.com/banking-finance/4116424/prana-biotechnology-pran-trading-down-5-3.html.

About Prana Biotechnology (NASDAQ:PRAN)

Prana Biotechnology Limited researches and develops therapeutic drugs for the treatment of Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidates include PBT434 that is in Phase I clinical trial for the treatment for Parkinson's disease and other movement disorders; and PBT2, which has completed four Phase I studies and a Phase IIa clinical trial for patients with Alzheimer's disease.

Recommended Story: Why do companies engage in swaps?

Receive News & Ratings for Prana Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prana Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

FuzzBalls  Price Hits $0.0018 on Exchanges
FuzzBalls Price Hits $0.0018 on Exchanges
Zeitcoin Achieves Market Cap of $389,704.00
Zeitcoin Achieves Market Cap of $389,704.00
EquiTrader Reaches 24 Hour Volume of $0.00
EquiTrader Reaches 24 Hour Volume of $0.00
Zacks: Analysts Expect Simply Good Foods Co  Will Post Quarterly Sales of $123.20 Million
Zacks: Analysts Expect Simply Good Foods Co Will Post Quarterly Sales of $123.20 Million
Brokerages Expect WellCare Health Plans, Inc.  Will Post Quarterly Sales of $6.54 Billion
Brokerages Expect WellCare Health Plans, Inc. Will Post Quarterly Sales of $6.54 Billion
Keysight Technologies  Hits New 52-Week High at $86.75
Keysight Technologies Hits New 52-Week High at $86.75


© 2006-2019 Ticker Report